{"id":11377,"date":"2025-01-04T19:08:08","date_gmt":"2025-01-04T19:08:08","guid":{"rendered":"https:\/\/www.info-welt.com\/en\/index.php\/2025\/01\/04\/vexas-syndrome-explained-what-you-need-to-know\/"},"modified":"2025-01-04T19:08:08","modified_gmt":"2025-01-04T19:08:08","slug":"vexas-syndrome-explained-what-you-need-to-know","status":"publish","type":"post","link":"https:\/\/www.info-welt.com\/en\/index.php\/2025\/01\/04\/vexas-syndrome-explained-what-you-need-to-know\/","title":{"rendered":"VEXAS Syndrome Explained: What You Need to Know"},"content":{"rendered":"<p><b>VEXAS syndrome<\/b> is a <b>rare genetic condition<\/b> that\\&#8217;s been puzzling medical researchers. It\\&#8217;s a complex <b>autoinflammatory disease<\/b>, recently discovered as a breakthrough in rare genetic disorders<sup class=\\\"citation\\\"><a href=\\\"https:\/\/www.nih.gov\/news-events\/nih-research-matters\/vexas-syndrome-more-common-realized\\\" target=\\\"_blank\\\" rel=\\\"nofollow\\\">1<\/a><\/sup>. This syndrome mainly affects older adults, especially men between 43 and 87 years old<sup class=\\\"citation\\\"><a href=\\\"https:\/\/www.verywellhealth.com\/vexas-syndrome-8673833\\\" target=\\\"_blank\\\" rel=\\\"nofollow\\\">2<\/a><\/sup>.<\/p>\n<p><b>VEXAS syndrome<\/b> is more common than once thought, affecting about 1 in 13,000 people<sup class=\\\"citation\\\"><a href=\\\"https:\/\/www.verywellhealth.com\/vexas-syndrome-8673833\\\" target=\\\"_blank\\\" rel=\\\"nofollow\\\">2<\/a><\/sup>. It causes unpredictable inflammation that can impact skin, lungs, and joints<sup class=\\\"citation\\\"><a href=\\\"https:\/\/www.verywellhealth.com\/vexas-syndrome-8673833\\\" target=\\\"_blank\\\" rel=\\\"nofollow\\\">2<\/a><\/sup>. Understanding this condition could be vital for many.<\/p>\n<p>Men are more at risk for this <b>autoinflammatory disease<\/b>. About 13,200 men in the U.S. may have it, compared to 2,300 women<sup class=\\\"citation\\\"><a href=\\\"https:\/\/www.verywellhealth.com\/vexas-syndrome-8673833\\\" target=\\\"_blank\\\" rel=\\\"nofollow\\\">2<\/a><\/sup>. NIH researchers identified the genetic mutation behind <b>VEXAS syndrome<\/b> in 2020<sup class=\\\"citation\\\"><a href=\\\"https:\/\/www.nih.gov\/news-events\/nih-research-matters\/vexas-syndrome-more-common-realized\\\" target=\\\"_blank\\\" rel=\\\"nofollow\\\">1<\/a><\/sup>.<\/p>\n<h3>Key Takeaways<\/h3>\n<ul>\n<li>VEXAS syndrome is a <b>rare genetic condition<\/b> affecting primarily older men<\/li>\n<li>Approximately 1 in 13,000 people may have this syndrome<\/li>\n<li>Symptoms can impact multiple body systems<\/li>\n<li>Genetic testing is crucial for diagnosis<\/li>\n<li>More research is needed to fully understand the condition<\/li>\n<\/ul>\n<h2>What is VEXAS Syndrome?<\/h2>\n<p>VEXAS syndrome is a rare medical mystery that fascinates researchers worldwide. This disorder combines complex biological mechanisms, challenging our grasp of genetic diseases. It\\&#8217;s a unique condition that affects multiple body systems.<\/p>\n<p>VEXAS stands for Vacuoles, E1 enzyme, X-linked, Autoinflammatory, Somatic syndrome. It\\&#8217;s marked by unusual inflammatory responses and genetic mutations. These changes impact various parts of the body<sup class=\\\"citation\\\"><a href=\\\"https:\/\/news.mayocliniclabs.com\/hematology\/myeloid-neoplasms\/vexas-syndrome\/\\\" target=\\\"_blank\\\" rel=\\\"nofollow\\\">3<\/a><\/sup>.<\/p>\n<h3>Understanding the Basics<\/h3>\n<p>VEXAS syndrome is a rare genetic disorder mainly affecting men. Its prevalence is noteworthy among older males.<\/p>\n<ul>\n<li>Approximately 1 in 4,000 men over 50 are estimated to be affected<sup class=\\\"citation\\\"><a href=\\\"https:\/\/news.mayocliniclabs.com\/hematology\/myeloid-neoplasms\/vexas-syndrome\/\\\" target=\\\"_blank\\\" rel=\\\"nofollow\\\">3<\/a><\/sup><\/li>\n<li>The syndrome occurs significantly less frequently in women<sup class=\\\"citation\\\"><a href=\\\"https:\/\/www.frontiersin.org\/journals\/oncology\/articles\/10.3389\/fonc.2024.1383730\/full\\\" target=\\\"_blank\\\" rel=\\\"nofollow\\\">4<\/a><\/sup><\/li>\n<\/ul>\n<h3>Historical Discovery<\/h3>\n<p><b>VEXAS discovery<\/b> came from intense medical research. Scientists found crucial insights about its genetic roots. They learned that specific mutations in the <b>UBA1 gene<\/b> cause the syndrome<sup class=\\\"citation\\\"><a href=\\\"https:\/\/ehoonline.biomedcentral.com\/articles\/10.1186\/s40164-021-00217-2\\\" target=\\\"_blank\\\" rel=\\\"nofollow\\\">5<\/a><\/sup>.<\/p>\n<blockquote><p>\\&#8221;VEXAS syndrome represents a breakthrough in understanding complex genetic inflammatory conditions.\\&#8221; &#8211; Medical Research Team<\/p><\/blockquote>\n<h3>Clinical Characteristics<\/h3>\n<table>\n<tr>\n<th>Characteristic<\/th>\n<th>Details<\/th>\n<\/tr>\n<tr>\n<td>Genetic Mutation<\/td>\n<td><b>UBA1 gene<\/b> mutation<\/td>\n<\/tr>\n<tr>\n<td>Primary Demographic<\/td>\n<td>Men over 50<\/td>\n<\/tr>\n<tr>\n<td>Associated Conditions<\/td>\n<td>Myelodysplastic Syndromes (MDS)<\/td>\n<\/tr>\n<\/table>\n<p>VEXAS syndrome shows intriguing links between genetic changes and inflammatory responses. Patients often face complex health issues. The condition may connect to <em>myelodysplastic syndromes<\/em> and other blood disorders<sup class=\\\"citation\\\"><a href=\\\"https:\/\/www.frontiersin.org\/journals\/oncology\/articles\/10.3389\/fonc.2024.1383730\/full\\\" target=\\\"_blank\\\" rel=\\\"nofollow\\\">4<\/a><\/sup>.<\/p>\n<h2>Symptoms of VEXAS Syndrome<\/h2>\n<p>VEXAS syndrome is a complex medical condition with various challenging symptoms. Early detection and management are crucial for this rare disorder.<\/p>\n<h3>Common VEXAS Syndrome Symptoms<\/h3>\n<p>VEXAS syndrome patients face several distinctive symptoms. These can greatly affect their daily lives.<\/p>\n<ul>\n<li>Recurrent high fevers<\/li>\n<li>Inflammatory conditions affecting multiple body systems<\/li>\n<li>Skin rashes and dermatitis<\/li>\n<li>Severe joint inflammation (arthritis)<\/li>\n<\/ul>\n<h3>Detailed Symptom Breakdown<\/h3>\n<p>VEXAS syndrome mainly affects middle-aged and older men. Its symptoms can be complex and unpredictable<sup class=\\\"citation\\\"><a href=\\\"https:\/\/www.medschool.umaryland.edu\/rpvexas\/vexas\/\\\" target=\\\"_blank\\\" rel=\\\"nofollow\\\">6<\/a><\/sup>.<\/p>\n<p>The condition may impact one in 4,269 men over 50 in the United States<sup class=\\\"citation\\\"><a href=\\\"https:\/\/www.health.com\/what-is-vexas-syndrome-7099742\\\" target=\\\"_blank\\\" rel=\\\"nofollow\\\">7<\/a><\/sup>.<\/p>\n<table>\n<tr>\n<th>Symptom Category<\/th>\n<th>Specific Manifestations<\/th>\n<\/tr>\n<tr>\n<td>Inflammatory Symptoms<\/td>\n<td>Cartilage inflammation, vasculitis, chondritis<\/td>\n<\/tr>\n<tr>\n<td>Blood-Related Symptoms<\/td>\n<td>Anemia, low platelets, blood clots<\/td>\n<\/tr>\n<tr>\n<td>Systemic Effects<\/td>\n<td>Recurrent fevers, fatigue, potential progression to blood cancer<\/td>\n<\/tr>\n<\/table>\n<h3>Individual Variation in Symptoms<\/h3>\n<p><b>VEXAS syndrome symptoms<\/b> vary greatly between individuals. Some patients experience mild issues, while others face severe complications<sup class=\\\"citation\\\"><a href=\\\"https:\/\/www.reumatologiaclinica.org\/en-vexas-syndrome-clinical-manifestations-diagnosis-articulo-S2173574323001661\\\" target=\\\"_blank\\\" rel=\\\"nofollow\\\">8<\/a><\/sup>.<\/p>\n<blockquote><p>Early diagnosis and treatment are critical due to the syndrome\\&#8217;s high potential for serious health impacts.<\/p><\/blockquote>\n<p>About 47% of diagnosed patients may face serious complications within five years. This highlights the need for thorough medical care<sup class=\\\"citation\\\"><a href=\\\"https:\/\/www.health.com\/what-is-vexas-syndrome-7099742\\\" target=\\\"_blank\\\" rel=\\\"nofollow\\\">7<\/a><\/sup>.<\/p>\n<h3>Potential Serious Complications<\/h3>\n<ul>\n<li>Myelodysplastic syndromes<\/li>\n<li>Potential progression to leukemia<\/li>\n<li>Chronic inflammatory conditions<\/li>\n<li>Increased risk of blood-related disorders<\/li>\n<\/ul>\n<p>Knowing these symptoms helps patients and doctors create effective management plans. This can improve overall quality of life for those with VEXAS syndrome.<\/p>\n<h2>Causes of VEXAS Syndrome<\/h2>\n<p>VEXAS syndrome stems from specific genetic changes. These changes impact your body\\&#8217;s cellular processes. Understanding its causes helps unravel its complex genetic landscape.<\/p>\n<h3>The Genetic Foundation of VEXAS<\/h3>\n<p>VEXAS syndrome comes from mutations in the <b>UBA1 gene<\/b>. This gene is crucial for protein regulation. These mutations affect how your immune cells work<sup class=\\\"citation\\\"><a href=\\\"https:\/\/medlineplus.gov\/genetics\/condition\/vexas-syndrome\/\\\" target=\\\"_blank\\\" rel=\\\"nofollow\\\">9<\/a><\/sup>.<\/p>\n<p>The condition is unique in several ways:<\/p>\n<ul>\n<li>Mutations occurring in specific immune and blood-forming cells<\/li>\n<li>Changes that reduce enzyme functionality<\/li>\n<li>Disruption of protein homeostasis<\/li>\n<\/ul>\n<h3>Who is Most Affected?<\/h3>\n<p>VEXAS syndrome mainly affects males in their later years. It\\&#8217;s most common in people aged fifty to seventy<sup class=\\\"citation\\\"><a href=\\\"https:\/\/en.wikipedia.org\/wiki\/VEXAS_syndrome\\\" target=\\\"_blank\\\" rel=\\\"nofollow\\\">10<\/a><\/sup>. The genetic mutation occurs on the X chromosome.<\/p>\n<p>This makes it more prevalent in those with a single X chromosome<sup class=\\\"citation\\\"><a href=\\\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC8462403\/\\\" target=\\\"_blank\\\" rel=\\\"nofollow\\\">11<\/a><\/sup>.<\/p>\n<h3>Cellular Impact of VEXAS Causes<\/h3>\n<p>UBA1 gene mutations lead to major cellular disruptions. These genetic changes cause several issues:<\/p>\n<ul>\n<li>Accumulation of damaged proteins<\/li>\n<li>Abnormal immune cell activation<\/li>\n<li>Impaired blood cell development<\/li>\n<\/ul>\n<p>Interestingly, VEXAS syndrome is acquired, not inherited<sup class=\\\"citation\\\"><a href=\\\"https:\/\/medlineplus.gov\/genetics\/condition\/vexas-syndrome\/\\\" target=\\\"_blank\\\" rel=\\\"nofollow\\\">9<\/a><\/sup>.<\/p>\n<blockquote><p>\\&#8221;Understanding genetic mutations is key to comprehending VEXAS syndrome\\&#8217;s complex nature.\\&#8221;<\/p><\/blockquote>\n<p>Ongoing research explores VEXAS causes\\&#8217; intricate mechanisms. This offers hope for better understanding and potential future treatments.<\/p>\n<h2>Diagnosis of VEXAS Syndrome<\/h2>\n<p>VEXAS syndrome is a rare and complex condition. Diagnosis requires a thorough clinical assessment and genetic testing<sup class=\\\"citation\\\"><a href=\\\"https:\/\/rmdopen.bmj.com\/content\/9\/3\/e003332\\\" target=\\\"_blank\\\" rel=\\\"nofollow\\\">12<\/a><\/sup>. Your healthcare team will guide you through this process.<\/p>\n<h3>Initial Assessment<\/h3>\n<p>The first step is a detailed medical evaluation. Doctors examine symptoms and medical history, focusing on specific indicators. For men over 50, certain clinical signs are crucial<sup class=\\\"citation\\\"><a href=\\\"https:\/\/dermnetnz.org\/topics\/vexas-syndrome\\\" target=\\\"_blank\\\" rel=\\\"nofollow\\\">13<\/a><\/sup>:<\/p>\n<ul>\n<li>Persistent systemic inflammation<\/li>\n<li>Multiorgan involvement<\/li>\n<li>Unexplained cytopenia<\/li>\n<\/ul>\n<h3>Diagnostic Tests<\/h3>\n<p><b>Genetic testing for VEXAS<\/b> is vital for confirming the diagnosis. Tests target the UBA1 gene to find mutations<sup class=\\\"citation\\\"><a href=\\\"https:\/\/rmdopen.bmj.com\/content\/9\/3\/e003332\\\" target=\\\"_blank\\\" rel=\\\"nofollow\\\">12<\/a><\/sup>. Your doctor will likely order several tests:<\/p>\n<table>\n<tr>\n<th>Test Type<\/th>\n<th>Purpose<\/th>\n<\/tr>\n<tr>\n<td>Blood Tests<\/td>\n<td>Check inflammatory markers and blood cell counts<sup class=\\\"citation\\\"><a href=\\\"https:\/\/dermnetnz.org\/topics\/vexas-syndrome\\\" target=\\\"_blank\\\" rel=\\\"nofollow\\\">13<\/a><\/sup><\/td>\n<\/tr>\n<tr>\n<td>Genetic Analysis<\/td>\n<td>Identify UBA1 gene variants<sup class=\\\"citation\\\"><a href=\\\"https:\/\/rmdopen.bmj.com\/content\/9\/3\/e003332\\\" target=\\\"_blank\\\" rel=\\\"nofollow\\\">12<\/a><\/sup><\/td>\n<\/tr>\n<tr>\n<td>Bone Marrow Examination<\/td>\n<td>Assess cellular changes and dysfunction<sup class=\\\"citation\\\"><a href=\\\"https:\/\/rmdopen.bmj.com\/content\/9\/3\/e003332\\\" target=\\\"_blank\\\" rel=\\\"nofollow\\\">12<\/a><\/sup><\/td>\n<\/tr>\n<\/table>\n<h3>Specialist Consultation<\/h3>\n<p><b>VEXAS diagnosis<\/b> often requires a team approach. You\\&#8217;ll likely see experts in <em>rheumatology, hematology, and genetics<\/em>. Their combined expertise ensures an accurate diagnosis<sup class=\\\"citation\\\"><a href=\\\"https:\/\/www.webmd.com\/men\/what-is-vexas\\\" target=\\\"_blank\\\" rel=\\\"nofollow\\\">14<\/a><\/sup>.<\/p>\n<blockquote><p>\\&#8221;Early and precise diagnosis is key to managing VEXAS syndrome effectively.\\&#8221; &#8211; Research Team<\/p><\/blockquote>\n<p>This rare condition affects about 13,200 men in the U.S. Specialized diagnostic techniques are crucial for proper identification<sup class=\\\"citation\\\"><a href=\\\"https:\/\/www.webmd.com\/men\/what-is-vexas\\\" target=\\\"_blank\\\" rel=\\\"nofollow\\\">14<\/a><\/sup>.<\/p>\n<h2>Treatment Options for VEXAS Syndrome<\/h2>\n<p><b>VEXAS syndrome management<\/b> requires a tailored approach. It combines various methods to address this rare inflammatory condition<sup class=\\\"citation\\\"><a href=\\\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC10468411\/\\\" target=\\\"_blank\\\" rel=\\\"nofollow\\\">15<\/a><\/sup>.<\/p>\n<p>Your unique health needs guide the treatment strategy. The goal is to manage symptoms and improve quality of life.<\/p>\n<p><div class=\"ast-oembed-container \" style=\"height: 100%;\"><iframe loading=\"lazy\" title=\"Therapeutic Options for VEXAS\" width=\"500\" height=\"281\" src=\"https:\/\/www.youtube.com\/embed\/u_rOxWuaLsw?feature=oembed\" frameborder=\"0\" allow=\"accelerometer; autoplay; clipboard-write; encrypted-media; gyroscope; picture-in-picture; web-share\" referrerpolicy=\"strict-origin-when-cross-origin\" allowfullscreen><\/iframe><\/div>\n<\/p>\n<h3>Targeted Medication Approaches<\/h3>\n<p><b>VEXAS treatment<\/b> often involves a carefully designed medication plan. Your healthcare team might suggest several options.<\/p>\n<ul>\n<li>Corticosteroids to reduce inflammation<\/li>\n<li>Immunosuppressive drugs to control immune system responses<\/li>\n<li>IL-6 inhibitors like tocilizumab to manage symptoms<sup class=\\\"citation\\\"><a href=\\\"https:\/\/molmed.biomedcentral.com\/articles\/10.1186\/s10020-024-00922-8\\\" target=\\\"_blank\\\" rel=\\\"nofollow\\\">16<\/a><\/sup><\/li>\n<\/ul>\n<h3>Personalized Management Strategies<\/h3>\n<p>Effective <b>VEXAS management<\/b> goes beyond medication. Your treatment plan may include additional elements.<\/p>\n<ol>\n<li>Regular medical monitoring<\/li>\n<li>Symptom-specific interventions<\/li>\n<li>Lifestyle modifications<\/li>\n<\/ol>\n<h3>Advanced Treatment Options<\/h3>\n<p>Severe cases might require more intensive treatments. <em>Allogeneic hematopoietic stem cell transplantation<\/em> could help patients with significant complications<sup class=\\\"citation\\\"><a href=\\\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC10468411\/\\\" target=\\\"_blank\\\" rel=\\\"nofollow\\\">15<\/a><\/sup>.<\/p>\n<blockquote><p>\\&#8221;Individualized care is crucial in managing VEXAS syndrome effectively\\&#8221; &#8211; Rheumatology Specialists<\/p><\/blockquote>\n<table>\n<tr>\n<th>Treatment Category<\/th>\n<th>Primary Goal<\/th>\n<th>Typical Interventions<\/th>\n<\/tr>\n<tr>\n<td>Pharmaceutical<\/td>\n<td>Reduce Inflammation<\/td>\n<td>Corticosteroids, Immunosuppressants<\/td>\n<\/tr>\n<tr>\n<td>Biological<\/td>\n<td>Immune Modulation<\/td>\n<td>IL-6 Inhibitors, JAK Inhibitors<\/td>\n<\/tr>\n<tr>\n<td>Supportive<\/td>\n<td>Symptom Management<\/td>\n<td>Physical Therapy, Lifestyle Adjustments<\/td>\n<\/tr>\n<\/table>\n<p>Your <b>VEXAS treatment<\/b> plan will be unique to you. Close collaboration with specialists ensures the best management strategy for your condition<sup class=\\\"citation\\\"><a href=\\\"https:\/\/molmed.biomedcentral.com\/articles\/10.1186\/s10020-024-00922-8\\\" target=\\\"_blank\\\" rel=\\\"nofollow\\\">16<\/a><\/sup>.<\/p>\n<h2>Living with VEXAS Syndrome<\/h2>\n<p><b>VEXAS syndrome management<\/b> requires a careful approach to daily life. Patients face unique challenges that need thoughtful strategies. Understanding how to handle this condition can boost quality of life<sup class=\\\"citation\\\"><a href=\\\"https:\/\/nyulangone.org\/news\/study-offers-first-glimpse-how-many-people-have-vexas-syndrome-recently-discovered-illness\\\" target=\\\"_blank\\\" rel=\\\"nofollow\\\">17<\/a><\/sup>.<\/p>\n<h3>Daily Management Strategies<\/h3>\n<p><b>VEXAS syndrome management<\/b> involves multiple key approaches:<\/p>\n<ul>\n<li>Regular medical monitoring<\/li>\n<li>Personalized pain management techniques<\/li>\n<li>Adaptive exercise routines<\/li>\n<li>Nutritional support<\/li>\n<\/ul>\n<p>About 13,200 men and 2,300 women over 50 in the U.S. have this condition<sup class=\\\"citation\\\"><a href=\\\"https:\/\/nyulangone.org\/news\/study-offers-first-glimpse-how-many-people-have-vexas-syndrome-recently-discovered-illness\\\" target=\\\"_blank\\\" rel=\\\"nofollow\\\">17<\/a><\/sup>. Patients should team up with doctors to create personalized treatment plans.<\/p>\n<h3>Supportive Resources<\/h3>\n<table>\n<tr>\n<th>Resource Type<\/th>\n<th>Description<\/th>\n<\/tr>\n<tr>\n<td>Support Groups<\/td>\n<td>Online and in-person communities for shared experiences<\/td>\n<\/tr>\n<tr>\n<td>Medical Counseling<\/td>\n<td>Specialized guidance for VEXAS syndrome management<\/td>\n<\/tr>\n<tr>\n<td>Educational Materials<\/td>\n<td>Latest research and coping strategies<\/td>\n<\/tr>\n<\/table>\n<blockquote><p><b>Living with VEXAS<\/b> requires resilience, knowledge, and a strong support network.<\/p><\/blockquote>\n<p>Men have a higher risk of VEXAS syndrome. <em>1 in 4,269 men over 50 may develop it<\/em><sup class=\\\"citation\\\"><a href=\\\"https:\/\/nyulangone.org\/news\/study-offers-first-glimpse-how-many-people-have-vexas-syndrome-recently-discovered-illness\\\" target=\\\"_blank\\\" rel=\\\"nofollow\\\">17<\/a><\/sup>. Knowing these facts helps patients and families prepare better.<\/p>\n<p>Many people manage VEXAS syndrome well despite its challenges. They do this through good care, staying informed, and keeping a positive attitude<sup class=\\\"citation\\\"><a href=\\\"https:\/\/www.nature.com\/articles\/s41433-024-03014-3\\\" target=\\\"_blank\\\" rel=\\\"nofollow\\\">18<\/a><\/sup>.<\/p>\n<h2>VEXAS Syndrome in Research<\/h2>\n<p><b>VEXAS research<\/b> is uncovering fascinating insights into this complex medical condition. Scientists are working hard to solve its mysteries. Their goal is to develop better diagnostic and treatment strategies.<\/p>\n<h3>Current Studies and Discoveries<\/h3>\n<p>Recent studies have revealed groundbreaking information about VEXAS syndrome\\&#8217;s prevalence. Researchers found that <em>1 in every 13,591 individuals harbors a UBA1 disease-causing variant<\/em><sup class=\\\"citation\\\"><a href=\\\"https:\/\/dceg.cancer.gov\/news-events\/news\/2023\/vexas-uba1\\\" target=\\\"_blank\\\" rel=\\\"nofollow\\\">19<\/a><\/sup>.<\/p>\n<p>This discovery significantly expands our understanding of the condition. The syndrome is more common in men over 50, with <em>1 in 4,269 affected<\/em><sup class=\\\"citation\\\"><a href=\\\"https:\/\/dceg.cancer.gov\/news-events\/news\/2023\/vexas-uba1\\\" target=\\\"_blank\\\" rel=\\\"nofollow\\\">19<\/a><\/sup>.<\/p>\n<ul>\n<li>The syndrome appears more prevalent in men over 50, with <em>1 in 4,269 affected<\/em><sup class=\\\"citation\\\"><a href=\\\"https:\/\/dceg.cancer.gov\/news-events\/news\/2023\/vexas-uba1\\\" target=\\\"_blank\\\" rel=\\\"nofollow\\\">19<\/a><\/sup><\/li>\n<li>Hematologic features, such as anemia, are present in 100% of participants with a VEXAS-associated variant<sup class=\\\"citation\\\"><a href=\\\"https:\/\/dceg.cancer.gov\/news-events\/news\/2023\/vexas-uba1\\\" target=\\\"_blank\\\" rel=\\\"nofollow\\\">19<\/a><\/sup><\/li>\n<li><b>VEXAS clinical trials<\/b> are exploring targeted treatment approaches<\/li>\n<\/ul>\n<h3>Future Research Directions<\/h3>\n<p><b>VEXAS clinical trials<\/b> are expanding to investigate several critical areas:<\/p>\n<ol>\n<li>Exploring genetic variations across diverse populations<\/li>\n<li>Understanding potential additional genes associated with VEXAS-like disorders<\/li>\n<li>Developing precision treatment strategies<\/li>\n<\/ol>\n<blockquote><p>The genome-first approach has proven more accurate in estimating disease prevalence compared to traditional clinical manifestation methods<sup class=\\\"citation\\\"><a href=\\\"https:\/\/dceg.cancer.gov\/news-events\/news\/2023\/vexas-uba1\\\" target=\\\"_blank\\\" rel=\\\"nofollow\\\">19<\/a><\/sup>.<\/p><\/blockquote>\n<p>Doctors suggest broad UBA1 testing for patients with certain symptoms. These include non-specific rheumatologic disorders and anemia. This highlights the importance of comprehensive screening<sup class=\\\"citation\\\"><a href=\\\"https:\/\/dceg.cancer.gov\/news-events\/news\/2023\/vexas-uba1\\\" target=\\\"_blank\\\" rel=\\\"nofollow\\\">19<\/a><\/sup>.<\/p>\n<p>As research moves forward, hope grows for better understanding of this complex syndrome. Improved diagnosis and management methods are on the horizon.<\/p>\n<h2>Understanding Genetic Testing<\/h2>\n<p>Genetic testing is crucial for diagnosing VEXAS syndrome. It\\&#8217;s a key tool when this rare inflammatory condition is suspected. Specialized <b>VEXAS genetic testing<\/b> helps healthcare providers make an accurate diagnosis<sup class=\\\"citation\\\"><a href=\\\"https:\/\/news.mayocliniclabs.com\/2023\/06\/14\/a-novel-testing-approach-for-newly-identified-vexas-syndrome\/\\\" target=\\\"_blank\\\" rel=\\\"nofollow\\\">20<\/a><\/sup>.<\/p>\n<h3>The Role of UBA1 Gene Testing<\/h3>\n<p><b>UBA1 gene testing<\/b> is vital for VEXAS syndrome diagnosis. It detects specific mutations that define the condition<sup class=\\\"citation\\\"><a href=\\\"https:\/\/www.diacarta.com\/genetic-testing-for-vexas\\\" target=\\\"_blank\\\" rel=\\\"nofollow\\\">21<\/a><\/sup>. Advanced techniques have been developed to identify these genetic changes precisely.<\/p>\n<ul>\n<li>Droplet digital PCR (ddPCR) offers a detection threshold of 0.5% for maximum sensitivity<sup class=\\\"citation\\\"><a href=\\\"https:\/\/news.mayocliniclabs.com\/2023\/06\/14\/a-novel-testing-approach-for-newly-identified-vexas-syndrome\/\\\" target=\\\"_blank\\\" rel=\\\"nofollow\\\">20<\/a><\/sup><\/li>\n<li>Next-generation sequencing provides faster and more cost-effective genomic profiling<sup class=\\\"citation\\\"><a href=\\\"https:\/\/www.diacarta.com\/genetic-testing-for-vexas\\\" target=\\\"_blank\\\" rel=\\\"nofollow\\\">21<\/a><\/sup><\/li>\n<li>Targeted analysis of seven specific loci in the UBA1 gene<sup class=\\\"citation\\\"><a href=\\\"https:\/\/news.mayocliniclabs.com\/2023\/06\/14\/a-novel-testing-approach-for-newly-identified-vexas-syndrome\/\\\" target=\\\"_blank\\\" rel=\\\"nofollow\\\">20<\/a><\/sup><\/li>\n<\/ul>\n<h3>Implications for Patients and Families<\/h3>\n<p><em>VEXAS syndrome is unique in its genetic presentation<\/em>. It results from somatic mutations acquired during a person\\&#8217;s lifetime. The syndrome affects about 1 in 4,000 men over 50 years old<sup class=\\\"citation\\\"><a href=\\\"https:\/\/news.mayocliniclabs.com\/2023\/06\/14\/a-novel-testing-approach-for-newly-identified-vexas-syndrome\/\\\" target=\\\"_blank\\\" rel=\\\"nofollow\\\">20<\/a><\/sup>.<\/p>\n<blockquote><p>Understanding your genetic profile can be a powerful tool in managing VEXAS syndrome and developing personalized treatment strategies.<\/p><\/blockquote>\n<h3>Advanced Testing Techniques<\/h3>\n<p>Modern genetic testing has transformed VEXAS syndrome diagnosis. The QClamps\u2122 Plex platform can detect UBA1 mutations at very low levels. It provides same-day results with high accuracy<sup class=\\\"citation\\\"><a href=\\\"https:\/\/www.diacarta.com\/genetic-testing-for-vexas\\\" target=\\\"_blank\\\" rel=\\\"nofollow\\\">21<\/a><\/sup>.<\/p>\n<p>Genetic testing offers valuable insights into VEXAS syndrome. However, it\\&#8217;s important to work with specialized healthcare professionals. They can accurately interpret these complex genetic findings.<\/p>\n<h2>Frequently Asked Questions about VEXAS Syndrome<\/h2>\n<p>VEXAS syndrome is a complex genetic condition. This section answers common questions to help you understand it better.<\/p>\n<h3>Top VEXAS Syndrome Questions Answered<\/h3>\n<p>VEXAS syndrome puzzles many patients and doctors. It affects about 15,000 people in the US<sup class=\\\"citation\\\"><a href=\\\"https:\/\/healthtree.org\/mds\/community\/articles\/vexas-syndrome-mds\\\" target=\\\"_blank\\\" rel=\\\"nofollow\\\">22<\/a><\/sup>.<\/p>\n<p>Understanding its details is vital for proper care. Let\\&#8217;s explore key aspects of this rare condition.<\/p>\n<ul>\n<li><em>What exactly is VEXAS syndrome?<\/em><br \/>\nA rare genetic disorder characterized by complex inflammatory symptoms that primarily impact males<sup class=\\\"citation\\\"><a href=\\\"https:\/\/omim.org\/entry\/301054\\\" target=\\\"_blank\\\" rel=\\\"nofollow\\\">23<\/a><\/sup>.<\/li>\n<li><em>Who is most likely to develop VEXAS?<\/em><br \/>\nMen around 64 years old are most susceptible, with symptoms typically emerging between 45-80 years of age<sup class=\\\"citation\\\"><a href=\\\"https:\/\/omim.org\/entry\/301054\\\" target=\\\"_blank\\\" rel=\\\"nofollow\\\">23<\/a><\/sup>.<\/li>\n<\/ul>\n<h3>Expert Insights on Diagnosis and Treatment<\/h3>\n<p>Diagnosing VEXAS syndrome needs thorough testing. This includes bone marrow biopsy and genetic analysis for UBA1 gene changes<sup class=\\\"citation\\\"><a href=\\\"https:\/\/healthtree.org\/mds\/community\/articles\/vexas-syndrome-mds\\\" target=\\\"_blank\\\" rel=\\\"nofollow\\\">22<\/a><\/sup>.<\/p>\n<p>Experts suggest a multi-faceted approach to manage the condition. Let\\&#8217;s look at some key diagnostic methods.<\/p>\n<table>\n<tr>\n<th>Diagnostic Method<\/th>\n<th>Key Findings<\/th>\n<\/tr>\n<tr>\n<td>Genetic Testing<\/td>\n<td>Identifies UBA1 gene mutations in patients<\/td>\n<\/tr>\n<tr>\n<td>Physical Examination<\/td>\n<td>Evaluates inflammatory symptoms<\/td>\n<\/tr>\n<\/table>\n<h3>Treatment Options<\/h3>\n<p>Treatment strategies vary but may include:<\/p>\n<ol>\n<li>Corticosteroids<\/li>\n<li>Immunosuppressants<\/li>\n<li>Monoclonal antibodies<\/li>\n<li>Bone marrow transplantation<sup class=\\\"citation\\\"><a href=\\\"https:\/\/healthtree.org\/mds\/community\/articles\/vexas-syndrome-mds\\\" target=\\\"_blank\\\" rel=\\\"nofollow\\\">22<\/a><\/sup><\/li>\n<\/ol>\n<blockquote><p>\n\\&#8221;Understanding VEXAS syndrome is key to effective management and improved patient outcomes.\\&#8221;\n<\/p><\/blockquote>\n<p>Scientists are exploring new treatments for VEXAS syndrome. Ongoing clinical trials offer hope for better care<sup class=\\\"citation\\\"><a href=\\\"https:\/\/healthtree.org\/mds\/community\/articles\/vexas-syndrome-mds\\\" target=\\\"_blank\\\" rel=\\\"nofollow\\\">22<\/a><\/sup>.<\/p>\n<h2>Community Support and Advocacy<\/h2>\n<p><b>Living with VEXAS<\/b> syndrome can feel isolating. But you\\&#8217;re not alone. Support groups and advocacy networks offer vital resources and connections<sup class=\\\"citation\\\"><a href=\\\"https:\/\/medlineplus.gov\/genetics\/condition\/vexas-syndrome\/\\\" target=\\\"_blank\\\" rel=\\\"nofollow\\\">9<\/a><\/sup>.<\/p>\n<p>Connecting with others who understand can be life-changing. <b>VEXAS advocacy<\/b> groups offer many ways to find support.<\/p>\n<ul>\n<li>Patient support networks<\/li>\n<li>Online discussion forums<\/li>\n<li>Educational webinars<\/li>\n<li>Resource sharing platforms<\/li>\n<\/ul>\n<h3>Patient Advocacy Groups<\/h3>\n<p>Organizations like NORD help rare disease communities. They offer emotional support and connect patients with specialists.<\/p>\n<p>These groups also fund research and raise public awareness. Their goal is to improve life for those with VEXAS syndrome.<\/p>\n<ol>\n<li>Offering emotional support<\/li>\n<li>Connecting patients with specialists<\/li>\n<li>Funding research initiatives<\/li>\n<li>Raising public awareness<\/li>\n<\/ol>\n<h3>Online Support Networks<\/h3>\n<p>Digital platforms have changed how VEXAS patients connect. Virtual groups let you share experiences and access new research.<\/p>\n<p>You can also find coping strategies and build a support network. These tools make managing VEXAS syndrome easier.<\/p>\n<ul>\n<li>Share personal experiences<\/li>\n<li>Access the latest research<\/li>\n<li>Find coping strategies<\/li>\n<li>Build a supportive community<\/li>\n<\/ul>\n<blockquote><p>\\&#8221;Knowledge shared is hope multiplied\\&#8221; &#8211; Anonymous VEXAS Syndrome Advocate<\/p><\/blockquote>\n<p><b>VEXAS support groups<\/b> offer more than just facts. They provide real understanding and friendship. You don\\&#8217;t have to face this alone.<\/p>\n<h2>Conclusion: Hope and Awareness for VEXAS Syndrome<\/h2>\n<p>VEXAS syndrome marks a crucial milestone in medical research. Your awareness can significantly impact patients with this complex condition. <a href=\\\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC10733701\/\\\" target=\\\"_blank\\\" rel=\\\"nofollow\\\">Studies show<\/a> VEXAS affects adult hematopoietic progenitor cells, influencing patient care<sup class=\\\"citation\\\"><a href=\\\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC10586336\/\\\" target=\\\"_blank\\\" rel=\\\"nofollow\\\">24<\/a><\/sup>.<\/p>\n<p>Growing <b>VEXAS awareness<\/b> drives advances in diagnosis and treatment. The syndrome\\&#8217;s complexity requires collaboration among healthcare professionals. Current treatments are limited, but research suggests promising targeted therapies<sup class=\\\"citation\\\"><a href=\\\"https:\/\/colab.ws\/articles\/10.1177%2F15353702231165030\\\" target=\\\"_blank\\\" rel=\\\"nofollow\\\">25<\/a><\/sup>.<\/p>\n<p>Patients can find hope in ongoing clinical studies exploring new management approaches<sup class=\\\"citation\\\"><a href=\\\"https:\/\/www.unboundmedicine.com\/medline\/journal\/Current_opinion_in_rheumatology\\\" target=\\\"_blank\\\" rel=\\\"nofollow\\\">26<\/a><\/sup>.<\/p>\n<h3>Importance of Awareness<\/h3>\n<p>Early detection of VEXAS relies on increased awareness. Your knowledge helps doctors recognize this rare condition\\&#8217;s unique challenges. Patients often experience fever, skin issues, and inflammatory responses<sup class=\\\"citation\\\"><a href=\\\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC10586336\/\\\" target=\\\"_blank\\\" rel=\\\"nofollow\\\">24<\/a><\/sup>.<\/p>\n<p>Spreading information contributes to faster diagnosis and better recognition. This awareness can lead to improved outcomes for those affected by VEXAS.<\/p>\n<h3>Looking Forward: VEXAS Future Treatments<\/h3>\n<p><b>VEXAS treatment<\/b> shows a bright future. New research targets the syndrome\\&#8217;s genetic mechanisms. Genetic testing and personalized medicine offer fresh hope for patients.<\/p>\n<p>As scientific understanding grows, future VEXAS treatments may improve management strategies. These advancements could transform patient care and enhance quality of life<sup class=\\\"citation\\\"><a href=\\\"https:\/\/colab.ws\/articles\/10.1177%2F15353702231165030\\\" target=\\\"_blank\\\" rel=\\\"nofollow\\\">25<\/a><\/sup>.<\/p>\n<section class=\\\"schema-section\\\">\n<h2>FAQ<\/h2>\n<div>\n<h3>What exactly is VEXAS syndrome?<\/h3>\n<div>\n<div>\n<p>VEXAS syndrome is a rare autoimmune condition caused by a UBA1 gene mutation. It mainly affects older men between 50 and 70 years old. The syndrome causes abnormal inflammation, recurring fevers, and complex health issues.<\/p>\n<\/div>\n<\/div>\n<\/div>\n<div>\n<h3>How common is VEXAS syndrome?<\/h3>\n<div>\n<div>\n<p>Recent studies show VEXAS syndrome affects about 1 in 13,000 people. It\\&#8217;s a <b>rare genetic condition<\/b> impacting specific immune and blood-forming cells.<\/p>\n<\/div>\n<\/div>\n<\/div>\n<div>\n<h3>What are the primary symptoms of VEXAS syndrome?<\/h3>\n<div>\n<div>\n<p>Common symptoms include inflammation of joints, skin, cartilage, and blood vessels. Patients may experience recurrent fevers, painful rashes, and blood clots.<\/p>\n<p>Other symptoms can include shortness of breath and blood cell abnormalities like anemia and thrombocytopenia.<\/p>\n<\/div>\n<\/div>\n<\/div>\n<div>\n<h3>Is VEXAS syndrome inherited?<\/h3>\n<div>\n<div>\n<p>No, VEXAS syndrome is not inherited. The genetic mutations are acquired during a person\\&#8217;s lifetime. They\\&#8217;re usually present only in certain immune and blood-forming cells in the bone marrow.<\/p>\n<\/div>\n<\/div>\n<\/div>\n<div>\n<h3>How is VEXAS syndrome diagnosed?<\/h3>\n<div>\n<div>\n<p>Diagnosis involves clinical assessment and genetic testing. Doctors evaluate symptoms and medical history, then test for UBA1 gene variants.<\/p>\n<p>Specialists in rheumatology, hematology, and genetics are often consulted for a thorough diagnosis.<\/p>\n<\/div>\n<\/div>\n<\/div>\n<div>\n<h3>What treatment options are available for VEXAS syndrome?<\/h3>\n<div>\n<div>\n<p>Treatment typically includes corticosteroids and immunosuppressants to manage inflammation. Severe cases might require bone marrow transplantation.<\/p>\n<p>Management also involves lifestyle changes, symptom control, and supportive care.<\/p>\n<\/div>\n<\/div>\n<\/div>\n<div>\n<h3>Can VEXAS syndrome be cured?<\/h3>\n<div>\n<div>\n<p>Currently, there\\&#8217;s no complete cure for VEXAS syndrome. Treatment aims to manage symptoms and improve quality of life. Ongoing research seeks to develop more targeted therapies as understanding grows.<\/p>\n<\/div>\n<\/div>\n<\/div>\n<div>\n<h3>Who is most at risk for developing VEXAS syndrome?<\/h3>\n<div>\n<div>\n<p>VEXAS syndrome mainly affects older men, with symptoms appearing in their 50s to 70s. It\\&#8217;s rare and more common in males due to its X-linked genetic mutation.<\/p>\n<\/div>\n<\/div>\n<\/div>\n<div>\n<h3>Are there support resources for people with VEXAS syndrome?<\/h3>\n<div>\n<div>\n<p>Yes, organizations like the National Organization for Rare Disorders (NORD) offer resources and support. Online communities provide platforms for sharing experiences and coping strategies.<\/p>\n<\/div>\n<\/div>\n<\/div>\n<div>\n<h3>What ongoing research is being conducted on VEXAS syndrome?<\/h3>\n<div>\n<div>\n<p>Current research explores the syndrome\\&#8217;s prevalence, symptoms, and treatment options. Studies investigate the condition in diverse populations and potential associated genes.<\/p>\n<p>Researchers are also working on developing targeted treatments to improve patient outcomes.<\/p>\n<\/div>\n<\/div>\n<\/div>\n<\/section>\n<h2>Source Links<\/h2>\n<ol data-type=\\\"sources\\\">\n<li>VEXAS syndrome more common than realized &#8211; <a href=\\\"https:\/\/www.nih.gov\/news-events\/nih-research-matters\/vexas-syndrome-more-common-realized\\\" target=\\\"_blank\\\" rel=\\\"nofollow\\\">https:\/\/www.nih.gov\/news-events\/nih-research-matters\/vexas-syndrome-more-common-realized<\/a><\/li>\n<li>What Is Autoinflammatory VEXAS Syndrome? &#8211; <a href=\\\"https:\/\/www.verywellhealth.com\/vexas-syndrome-8673833\\\" target=\\\"_blank\\\" rel=\\\"nofollow\\\">https:\/\/www.verywellhealth.com\/vexas-syndrome-8673833<\/a><\/li>\n<li>VEXAS syndrome &#8211; Insights &#8211; <a href=\\\"https:\/\/news.mayocliniclabs.com\/hematology\/myeloid-neoplasms\/vexas-syndrome\/\\\" target=\\\"_blank\\\" rel=\\\"nofollow\\\">https:\/\/news.mayocliniclabs.com\/hematology\/myeloid-neoplasms\/vexas-syndrome\/<\/a><\/li>\n<li>Frontiers | Successful treatment with fludarabine and cyclophosphamide in a VEXAS syndrome patient with associated myelodysplastic syndrome: a case report and systematic review &#8211; <a href=\\\"https:\/\/www.frontiersin.org\/journals\/oncology\/articles\/10.3389\/fonc.2024.1383730\/full\\\" target=\\\"_blank\\\" rel=\\\"nofollow\\\">https:\/\/www.frontiersin.org\/journals\/oncology\/articles\/10.3389\/fonc.2024.1383730\/full<\/a><\/li>\n<li>VEXAS syndrome in myelodysplastic syndrome with autoimmune disorder &#8211; Experimental Hematology &amp; Oncology &#8211; <a href=\\\"https:\/\/ehoonline.biomedcentral.com\/articles\/10.1186\/s40164-021-00217-2\\\" target=\\\"_blank\\\" rel=\\\"nofollow\\\">https:\/\/ehoonline.biomedcentral.com\/articles\/10.1186\/s40164-021-00217-2<\/a><\/li>\n<li>University of Maryland School of Medicine &#8211; <a href=\\\"https:\/\/www.medschool.umaryland.edu\/rpvexas\/vexas\/\\\" target=\\\"_blank\\\" rel=\\\"nofollow\\\">https:\/\/www.medschool.umaryland.edu\/rpvexas\/vexas\/<\/a><\/li>\n<li>VEXAS Syndrome Is More Common Than Once Thought &#8211; <a href=\\\"https:\/\/www.health.com\/what-is-vexas-syndrome-7099742\\\" target=\\\"_blank\\\" rel=\\\"nofollow\\\">https:\/\/www.health.com\/what-is-vexas-syndrome-7099742<\/a><\/li>\n<li>VEXAS syndrome: Clinical manifestations, diagnosis, and treatment | Reumatolog\u00eda Cl\u00ednica &#8211; <a href=\\\"https:\/\/www.reumatologiaclinica.org\/en-vexas-syndrome-clinical-manifestations-diagnosis-articulo-S2173574323001661\\\" target=\\\"_blank\\\" rel=\\\"nofollow\\\">https:\/\/www.reumatologiaclinica.org\/en-vexas-syndrome-clinical-manifestations-diagnosis-articulo-S2173574323001661<\/a><\/li>\n<li>VEXAS syndrome: MedlinePlus Genetics &#8211; <a href=\\\"https:\/\/medlineplus.gov\/genetics\/condition\/vexas-syndrome\/\\\" target=\\\"_blank\\\" rel=\\\"nofollow\\\">https:\/\/medlineplus.gov\/genetics\/condition\/vexas-syndrome\/<\/a><\/li>\n<li>VEXAS syndrome &#8211; <a href=\\\"https:\/\/en.wikipedia.org\/wiki\/VEXAS_syndrome\\\" target=\\\"_blank\\\" rel=\\\"nofollow\\\">https:\/\/en.wikipedia.org\/wiki\/VEXAS_syndrome<\/a><\/li>\n<li>VEXAS syndrome &#8211; PMC &#8211; <a href=\\\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC8462403\/\\\" target=\\\"_blank\\\" rel=\\\"nofollow\\\">https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC8462403\/<\/a><\/li>\n<li>VEXAS syndrome: a diagnostic puzzle &#8211; <a href=\\\"https:\/\/rmdopen.bmj.com\/content\/9\/3\/e003332\\\" target=\\\"_blank\\\" rel=\\\"nofollow\\\">https:\/\/rmdopen.bmj.com\/content\/9\/3\/e003332<\/a><\/li>\n<li>VEXAS syndrome &#8211; <a href=\\\"https:\/\/dermnetnz.org\/topics\/vexas-syndrome\\\" target=\\\"_blank\\\" rel=\\\"nofollow\\\">https:\/\/dermnetnz.org\/topics\/vexas-syndrome<\/a><\/li>\n<li>What Is VEXAS? &#8211; <a href=\\\"https:\/\/www.webmd.com\/men\/what-is-vexas\\\" target=\\\"_blank\\\" rel=\\\"nofollow\\\">https:\/\/www.webmd.com\/men\/what-is-vexas<\/a><\/li>\n<li>VEXAS syndrome: Current clinical, diagnostic and treatment approaches &#8211; <a href=\\\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC10468411\/\\\" target=\\\"_blank\\\" rel=\\\"nofollow\\\">https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC10468411\/<\/a><\/li>\n<li>Navigating therapeutic challenges in VEXAS syndrome: exploring IL-6 and JAK inhibitors at the forefront &#8211; Molecular Medicine &#8211; <a href=\\\"https:\/\/molmed.biomedcentral.com\/articles\/10.1186\/s10020-024-00922-8\\\" target=\\\"_blank\\\" rel=\\\"nofollow\\\">https:\/\/molmed.biomedcentral.com\/articles\/10.1186\/s10020-024-00922-8<\/a><\/li>\n<li>Study Offers First Glimpse of How Many People Have VEXAS Syndrome, a Recently Discovered Illness &#8211; <a href=\\\"https:\/\/nyulangone.org\/news\/study-offers-first-glimpse-how-many-people-have-vexas-syndrome-recently-discovered-illness\\\" target=\\\"_blank\\\" rel=\\\"nofollow\\\">https:\/\/nyulangone.org\/news\/study-offers-first-glimpse-how-many-people-have-vexas-syndrome-recently-discovered-illness<\/a><\/li>\n<li>Ocular and orbital manifestations in VEXAS syndrome &#8211; Eye &#8211; <a href=\\\"https:\/\/www.nature.com\/articles\/s41433-024-03014-3\\\" target=\\\"_blank\\\" rel=\\\"nofollow\\\">https:\/\/www.nature.com\/articles\/s41433-024-03014-3<\/a><\/li>\n<li>Genome-First Study Finds High Prevalence of VEXAS Syndrome &#8211; <a href=\\\"https:\/\/dceg.cancer.gov\/news-events\/news\/2023\/vexas-uba1\\\" target=\\\"_blank\\\" rel=\\\"nofollow\\\">https:\/\/dceg.cancer.gov\/news-events\/news\/2023\/vexas-uba1<\/a><\/li>\n<li>A novel testing approach for newly identified VEXAS syndrome &#8211; Insights &#8211; <a href=\\\"https:\/\/news.mayocliniclabs.com\/2023\/06\/14\/a-novel-testing-approach-for-newly-identified-vexas-syndrome\/\\\" target=\\\"_blank\\\" rel=\\\"nofollow\\\">https:\/\/news.mayocliniclabs.com\/2023\/06\/14\/a-novel-testing-approach-for-newly-identified-vexas-syndrome\/<\/a><\/li>\n<li>Genetic Testing for the VEXAS Syndrome &#8211; DiaCarta, Inc. &#8211; <a href=\\\"https:\/\/www.diacarta.com\/genetic-testing-for-vexas\\\" target=\\\"_blank\\\" rel=\\\"nofollow\\\">https:\/\/www.diacarta.com\/genetic-testing-for-vexas<\/a><\/li>\n<li>What You Need to Know About VEXAS Syndrome &#8211; HealthTree for Myelodysplastic Syndromes &#8211; <a href=\\\"https:\/\/healthtree.org\/mds\/community\/articles\/vexas-syndrome-mds\\\" target=\\\"_blank\\\" rel=\\\"nofollow\\\">https:\/\/healthtree.org\/mds\/community\/articles\/vexas-syndrome-mds<\/a><\/li>\n<li>No title found &#8211; <a href=\\\"https:\/\/omim.org\/entry\/301054\\\" target=\\\"_blank\\\" rel=\\\"nofollow\\\">https:\/\/omim.org\/entry\/301054<\/a><\/li>\n<li>A Double Hit to Ubiquitination Leading to a New Diagnosis of VEXAS Syndrome &#8211; <a href=\\\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC10586336\/\\\" target=\\\"_blank\\\" rel=\\\"nofollow\\\">https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC10586336\/<\/a><\/li>\n<li>JAK inhibitors for the treatment of VEXAS syndrome &#8211; <a href=\\\"https:\/\/colab.ws\/articles\/10.1177%2F15353702231165030\\\" target=\\\"_blank\\\" rel=\\\"nofollow\\\">https:\/\/colab.ws\/articles\/10.1177\/15353702231165030<\/a><\/li>\n<li>PRIME PubMed | Current opinion in rheumatology journal articles from PubMed &#8211; <a href=\\\"https:\/\/www.unboundmedicine.com\/medline\/journal\/Current_opinion_in_rheumatology\\\" target=\\\"_blank\\\" rel=\\\"nofollow\\\">https:\/\/www.unboundmedicine.com\/medline\/journal\/Current_opinion_in_rheumatology<\/a><\/li>\n<\/ol>\n","protected":false},"excerpt":{"rendered":"<p>Discover the key facts about VEXAS Syndrome, its symptoms, and treatment options. Learn how this rare genetic condition affects the body and what steps you can take for better management<\/p>\n","protected":false},"author":1,"featured_media":11379,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_uag_custom_page_level_css":"","site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"default","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","ast-disable-related-posts":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"footnotes":""},"categories":[5],"tags":[126,127,128,129],"class_list":["post-11377","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-health","tag-clinical-diagnosis","tag-hematologic-symptoms","tag-inflammatory-syndrome","tag-vexas-syndrome"],"uagb_featured_image_src":{"full":false,"thumbnail":false,"medium":false,"medium_large":false,"large":false,"1536x1536":false,"2048x2048":false},"uagb_author_info":{"display_name":"wpmanag984","author_link":"https:\/\/www.info-welt.com\/en\/author\/wpmanag984\/"},"uagb_comment_info":0,"uagb_excerpt":"Discover the key facts about VEXAS Syndrome, its symptoms, and treatment options. Learn how this rare genetic condition affects the body and what steps you can take for better management","_links":{"self":[{"href":"https:\/\/www.info-welt.com\/en\/index.php\/wp-json\/wp\/v2\/posts\/11377","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.info-welt.com\/en\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.info-welt.com\/en\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.info-welt.com\/en\/index.php\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.info-welt.com\/en\/index.php\/wp-json\/wp\/v2\/comments?post=11377"}],"version-history":[{"count":0,"href":"https:\/\/www.info-welt.com\/en\/index.php\/wp-json\/wp\/v2\/posts\/11377\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.info-welt.com\/en\/index.php\/wp-json\/wp\/v2\/media?parent=11377"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.info-welt.com\/en\/index.php\/wp-json\/wp\/v2\/categories?post=11377"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.info-welt.com\/en\/index.php\/wp-json\/wp\/v2\/tags?post=11377"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}